Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015

Jeevan Scientific Technology Limited Jo eguadiy lo st Ref: JSTL/BOD/BSE/2026-27/ OCT26 Date: October 01, 2026 The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001. Dear Sir/Madam, Unit: Jeevan Scientific Technology Limited (Scrip Code: 538837) Sub: Closure of the United States Food and Drug Administration (US FDA) Inspection of JSTL and issuance of the Establishment Inspection Report (EIR), received by the Company on 30.09.2026 - Corporate Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015. Ref: Company’s earlier disclosure on the above subject on 24.07.2026. In continuation of the disclosure cited above on the inspection of the Company’s Bioanalytical Facility located at Manikonda, Hyderabad, conducted by the United States Food and Drug Administration (US FDA) from 20% July, 2026 to 24 July, 2026, which has been successfully closed with No Observations (Zero 483s). This is to further inform that, the US FDA has concluded the inspection under 21 CFR 20.64(d)(3) and has released the Establishment Inspection Report (EIR) on 30 September, 2026. Thanking You. Yours faithfully, For Jeevan Scientific Technology Limited Krishna Sainadh Kodati Company Secretary & Compliance Officer Registered Office: Plot No. 1&2, Sai Krupa Enclave, Near Lanco Hills, Golconda Post, Hyderabad- 500 008, T.5., India. Tel: +91-40-67364700 Email: info@jeevanscientific.com Web: www.jeevanscientific.com CIN: L72200TG1999PLC031016